Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glenmark’s molecule for Osteoarthritic and Neuropathic Pain, GRC 15300, to enter Phase I trials
Glenmark’s molecule for Osteoarthritic and Neuropathic Pain, GRC 15300, to enter Phase I trials
Glenmark’s molecule for Osteoarthritic and Neuropathic Pain, GRC 15300, to enter Phase I trials
Submitted by
admin
on January 24, 2009 - 12:51pm
Source:
Pipeline Review
News Tags:
Glenmark
GRC 15300
Headline:
Glenmark’s molecule for Osteoarthritic and Neuropathic Pain, GRC 15300, to enter Phase I trials
Do Not Allow Advertisers to Use My Personal information
